Arbutus Biopharma Corporation (ABUS)

NASDAQ

$4.46

$-0.08

(-1.75%)

Previous Close: ⁦$4.56⁩

Market Closed

Arbutus Biopharma Corporation (ABUS) Live Price Chart

Last updated: ⁦2026-10-03 01:04:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Arbutus Biopharma Corporation (ABUS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.46, with a market capitalisation of $946.95M and a P/E ratio of 5.90. Over the past 52 weeks, its price has ranged from $3.50 to $5.45. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$946.95M
Open	$4.55
Day's High	$12.60
Day's Low	$0.82
Previous Close	$4.56
Volume	7.92M
Average Volume	4.48M
P/E Ratio	5.90
52-Week High	$5.45
52-Week Low	$3.50
Dividend Yield	--
Earnings Date	--

Arbutus Biopharma Corporation (ABUS) Latest Closing Stock Price

Arbutus Biopharma Corporation (ABUS) last closed at $4.56 as of 2026-10-02 23:31:00, unchanged from the previous close of $4.56.

During the latest regular trading session, ABUS traded between $0.82 and $12.60, with a volume of 7.92M shares. The closing price was near the lower end and near the middle of its 52-week range.

Arbutus Biopharma Corporation (ABUS) 7-Day Stock Price Change

Over the past seven days, Arbutus Biopharma Corporation (ABUS) moved from $4.85 to $4.46, representing a decline of 8.14% ($0.39).

The stock traded between $4.38 and $5.02 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 13.74 million shares, up versus the previous seven-day period, indicating higher trading activity.

ABUS 52-Week Price Position

Position in Range: 49.0%

52W Low$3.50

52W High$5.45

ABUS is currently trading at $4.46, placing it 49.0% of the way from its 52-week low of $3.50 to its 52-week high of $5.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Arbutus Biopharma Corporation (ABUS)?

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Arbutus Biopharma Corporation Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	19
Exchange	NASDAQ
Company Website	http://www.arbutusbio.com

How to Buy Arbutus Biopharma Corporation (ABUS) Stock on MEXC

Eligible investors can buy real shares of Arbutus Biopharma Corporation (ABUS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ABUS and Place Your Order

Open the RealStocks trading page and search for ABUS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Arbutus Biopharma Corporation (ABUS) share price today?

Arbutus Biopharma Corporation (ABUS) is currently trading at $ 4.46, down 2.30% ($0.10) from the previous close of $ 4.56. Intraday prices update in real time during regular trading hours.

2.Is ABUS stock going up or down today?

As of 2026-10-02 23:31:00, ABUS is trading at $ 4.46, down 2.30% ($0.10) from its previous close of $ 4.56. The stock has traded between $ 0.82 and $ 12.60 during today’s regular session. Past price movements do not guarantee future results.

3.What is ABUS pre-market price?

As of 2026-10-02 23:31:00, ABUS is trading at $ 4.62 in pre-market trading, up 1.32% ($0.06) from the previous close of $ 4.56. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ABUS after-hours price?

As of 2026-10-02 23:31:00, ABUS is trading at $ 4.45 in after-hours trading, down 2.41% ($0.11) from the regular-session close of $ 4.56. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is ABUS stock trading now?

ABUS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ABUS sit relative to its 52-week high and low?

Over the past 52 weeks, ABUS has traded between a low of $ 3.50 and a high of $ 5.45. At $ 4.46, the stock is positioned 49.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Arbutus Biopharma Corporation in?

Arbutus Biopharma Corporation (ABUS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Arbutus Biopharma Corporation's market capitalisation and where is it listed?

Arbutus Biopharma Corporation is listed on the NASDAQ exchange with a market capitalisation of $ 946.95M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ABUS valued in terms of P/E ratio and EPS?

ABUS trades at a P/E ratio of 5.90, based on trailing-twelve-month EPS of $ 0.77. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Arbutus Biopharma Corporation pay a dividend?

Arbutus Biopharma Corporation pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.